CLSA Capital Partners invests $10 million in Camson Bio Technologies

May 9, 2013 |

In Hong Kong, DealCurry reports that CLSA Capital Partners is investing $10 million in Camson Bio Technologies. In return, Camson will issue over 41 million shares at $1.1 per share, and over 16 million convertible warrants priced at $3.21 each. The articles states that will give CLSA a 19.6% stake in Camson. Camson is a Bangalore-based company that produces hybrid seeds, biofertilizers and biopestices.

Print Friendly, PDF & Email

Tags: , ,

Category: International

Thank you for visting the Digest.